e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Pathogenesis and risk of lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Recombination of B7-H4 and CD68 predicted lymph node metastasis in human lung carcinoma
J. A. Huang, C. Chen (Suzhou, China)
Source:
Annual Congress 2013 –Pathogenesis and risk of lung cancer
Session:
Pathogenesis and risk of lung cancer
Session type:
Thematic Poster Session
Number:
4514
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. A. Huang, C. Chen (Suzhou, China). Recombination of B7-H4 and CD68 predicted lymph node metastasis in human lung carcinoma. Eur Respir J 2013; 42: Suppl. 57, 4514
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Mediastinal lymph nodes (MLN) vascular pattern utilitiy to predict progression in lung cancer
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Is primary tumor metabolic activity a risk factor for occult lymph node metastasis in T1-2N0M0 non-small cell lung cancer patients?
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Regulatory vs. cytotoxic cells in lymph nodes of lung cancer patients resected by TEMLA
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016
The affect of the metabolic activity of the primary tumor to lymph node and distant metastasis in non-small cell lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Analysis of FOXP3 expression in the lymph nodes of patients with lung adenocarcinoma- The pilot study
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
CD163 and CCR7 markers for macrophage polarisation in patients with lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016
Myeloid antigen presenting cells in lung adenocarcinoma lymph nodes assessed by endobronchial ultrasound
Source: International Congress 2016 – Endosonography: EBUS/EUS (B)
Year: 2016
Macrophages promote urethane-induced lung adenocarcinoma
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015
Differences in expression and prognostic values of p16(ink) and VEGF in squamous and adenocarcinoma of the lung
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Breast metastasis from primary EGFR-mutated lung carcinoma or primary tumor?
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016
Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Intrathoracic lymph node staging of potentially resectable non-small cell lung cancer - The role of PET-CT
Source: International Congress 2015 – Developments in lung cancer diagnosis
Year: 2015
Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Ultrasound guided true cut biopsy of peripheral lymph nodes as a staging procedure in patients with non-small cell lung cancer (NSCLC)
Source: International Congress 2016 – EBUS and transthoracic ultrasound
Year: 2016
IL-17C promotes tumor-associated inflammation and lung tumor growth
Source: International Congress 2016 – Late-breaking translational research in lung cancer
Year: 2016
Relationship of T status and metastasis according to new clinical TNM staging in non small cell lung carcinoma
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015
Significance of age, tumor location and histological subtype in lung cancer with brain metastasis
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Profile of non-neoplasic mediastinal lymph nodes (NNLN) during the study of lung cáncer (LC)
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Immunohistochemical expression of nuclear factor kappa-B/p65 and cyclooxygenase-2 in non-small cell lung cancer patients: Prognostic value and impact on survival
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014
Recruitment and phenotypic characteristics of interleukin 9−Producing CD4
+
T cells in malignant pleural effusion
Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept